• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型头孢菌素缀合物对碳青霉烯酶型金属β-内酰胺酶表现出强大且选择性的抑制作用。

Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases.

机构信息

Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.

Division of Cell Biology, Department of Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.

出版信息

J Med Chem. 2021 Jul 8;64(13):9141-9151. doi: 10.1021/acs.jmedchem.1c00362. Epub 2021 Jun 28.

DOI:10.1021/acs.jmedchem.1c00362
PMID:34182755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8273888/
Abstract

In an attempt to exploit the hydrolytic mechanism by which β-lactamases degrade cephalosporins, we designed and synthesized a series of novel cephalosporin prodrugs aimed at delivering thiol-based inhibitors of metallo-β-lactamases (MBLs) in a spatiotemporally controlled fashion. While enzymatic hydrolysis of the β-lactam ring was observed, it was not accompanied by inhibitor release. Nonetheless, the cephalosporin prodrugs, especially thiomandelic acid conjugate (), demonstrated potent inhibition of IMP-type MBLs. In addition, conjugate was also found to greatly reduce the minimum inhibitory concentration of meropenem against IMP-producing bacteria. The results of kinetic experiments indicate that these prodrugs inhibit IMP-type MBLs by acting as slowly turned-over substrates. Structure-activity relationship studies revealed that both phenyl and carboxyl moieties of are crucial for its potency. Furthermore, modeling studies indicate that productive interactions of the thiomandelic acid moiety of with Trp28 within the IMP active site may contribute to its potency and selectivity.

摘要

为了利用β-内酰胺酶降解头孢菌素的水解机制,我们设计并合成了一系列新型头孢菌素前药,旨在以时空控制的方式递送基于硫醇的金属β-内酰胺酶(MBL)抑制剂。虽然观察到β-内酰胺环的酶水解,但没有伴随抑制剂释放。尽管如此,头孢菌素前药,特别是硫代扁桃酸共轭物(),对 IMP 型 MBL 表现出很强的抑制作用。此外,还发现共轭物可大大降低产 IMP 的细菌对美罗培南的最小抑菌浓度。动力学实验结果表明,这些前药通过充当缓慢转化的底物来抑制 IMP 型 MBL。构效关系研究表明,共轭物的苯和羧基部分对于其效力都是至关重要的。此外,建模研究表明,与 IMP 活性位点中的 Trp28 进行生产性相互作用可能有助于其效力和选择性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/e1640502c8b2/jm1c00362_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/dae6cb16b5f1/jm1c00362_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/c009ee5ac56c/jm1c00362_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/49bb6a9b2739/jm1c00362_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/732208ec0732/jm1c00362_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/e1640502c8b2/jm1c00362_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/dae6cb16b5f1/jm1c00362_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/c009ee5ac56c/jm1c00362_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/49bb6a9b2739/jm1c00362_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/732208ec0732/jm1c00362_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/8273888/e1640502c8b2/jm1c00362_0005.jpg

相似文献

1
Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases.新型头孢菌素缀合物对碳青霉烯酶型金属β-内酰胺酶表现出强大且选择性的抑制作用。
J Med Chem. 2021 Jul 8;64(13):9141-9151. doi: 10.1021/acs.jmedchem.1c00362. Epub 2021 Jun 28.
2
Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.头孢菌素前药抑制剂克服金属β-内酰胺酶驱动的抗生素耐药性。
Chemistry. 2021 Feb 19;27(11):3806-3811. doi: 10.1002/chem.202004694. Epub 2021 Jan 8.
3
Hdpa derivatives containing pentadentate ligands: An acyclic adjuvant potentiates meropenem activity in vitro and in vivo against metallo-β-lactamase-producing Enterobacterales.含五齿配体的 Hdpa 衍生物:一种无环佐剂可增强美罗培南对产金属β-内酰胺酶肠杆菌科的体外和体内活性。
Eur J Med Chem. 2021 Nov 15;224:113702. doi: 10.1016/j.ejmech.2021.113702. Epub 2021 Jul 13.
4
A Cephalosporin-Tripodalamine Conjugate Inhibits Metallo-β-Lactamase with High Efficacy and Low Toxicity.一种头孢菌素-三足形胺缀合物高效低毒抑制金属β-内酰胺酶。
Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0035222. doi: 10.1128/aac.00352-22. Epub 2022 Sep 12.
5
Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.靶向临床相关金属β-内酰胺酶:从高通量对接至广谱抑制剂
J Enzyme Inhib Med Chem. 2016;31(sup1):98-109. doi: 10.3109/14756366.2016.1172575. Epub 2016 Apr 28.
6
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.基于片段的计算设计鉴定 B1 金属β-内酰胺酶抑制剂。
J Med Chem. 2018 Feb 8;61(3):1255-1260. doi: 10.1021/acs.jmedchem.7b01728. Epub 2018 Jan 10.
7
Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors.某些芳基磺酰基腙与 1,3-二芳基吡唑偶联物作为有效的金属β-内酰胺酶抑制剂的设计、合成、生物评价及计算机研究。
Bioorg Chem. 2020 Dec;105:104386. doi: 10.1016/j.bioorg.2020.104386. Epub 2020 Oct 20.
8
Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.设计、合成及对金属β-内酰胺酶 IMP-1 具有高抑制活性的氨基酸衍生硫醇抑制剂的体外和生物学评价。
Eur J Med Chem. 2016 May 23;114:318-27. doi: 10.1016/j.ejmech.2016.03.017. Epub 2016 Mar 9.
9
Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.立体化学修饰的头孢菌素作为新型德里金属β-内酰胺酶的强效抑制剂。
Eur J Med Chem. 2022 Mar 15;232:114174. doi: 10.1016/j.ejmech.2022.114174. Epub 2022 Feb 4.
10
Synthesis and investigation of inhibitory activities of imidazole derivatives against the metallo-β-lactamase IMP-1.合成及咪唑衍生物对金属β-内酰胺酶 IMP-1 的抑制活性的研究。
Bioorg Chem. 2019 Nov;92:103277. doi: 10.1016/j.bioorg.2019.103277. Epub 2019 Sep 12.

引用本文的文献

1
Cefiderocol "under siege"? Understanding the rise of NDM-mediated resistance to novel agents.头孢地尔“被围攻”?解读NDM介导的对新型药物耐药性的上升。
Chem Sci. 2025 Jun 3. doi: 10.1039/d5sc02122g.
2
Breakthrough Advances in Beta-Lactamase Inhibitors: New Synthesized Compounds and Mechanisms of Action Against Drug-Resistant Bacteria.β-内酰胺酶抑制剂的突破性进展:新合成化合物及抗耐药菌作用机制
Pharmaceuticals (Basel). 2025 Feb 3;18(2):206. doi: 10.3390/ph18020206.
3
Synthesis of Novel 3-spirocephalosporins and Evaluation of their Antibacterial Activity.

本文引用的文献

1
Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.金属β-内酰胺酶抑制剂的作用机制研究:强烈的锌结合对于有效的酶抑制并非必需*。
ChemMedChem. 2021 May 18;16(10):1651-1659. doi: 10.1002/cmdc.202100042. Epub 2021 Mar 3.
2
Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.头孢菌素前药抑制剂克服金属β-内酰胺酶驱动的抗生素耐药性。
Chemistry. 2021 Feb 19;27(11):3806-3811. doi: 10.1002/chem.202004694. Epub 2021 Jan 8.
3
Probing the mechanisms of inhibition for various inhibitors of metallo-β-lactamases VIM-2 and NDM-1.
新型3-螺环头孢菌素的合成及其抗菌活性评价
Curr Org Synth. 2025;22(5):620-630. doi: 10.2174/0115701794287416241119111826.
4
Approachable Synthetic Methodologies for Second-Generation -Lactamase Inhibitors: A Review.第二代β-内酰胺酶抑制剂的便捷合成方法:综述
Pharmaceuticals (Basel). 2024 Aug 23;17(9):1108. doi: 10.3390/ph17091108.
5
An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting.一种工程前药在混合微生物环境中选择性抑制β-内酰胺耐药菌。
bioRxiv. 2024 Aug 3:2024.08.02.606422. doi: 10.1101/2024.08.02.606422.
6
Plant antibacterials: The challenges and opportunities.植物抗菌剂:挑战与机遇
Heliyon. 2024 May 11;10(10):e31145. doi: 10.1016/j.heliyon.2024.e31145. eCollection 2024 May 30.
7
Rational Design of Benzobisheterocycle Metallo-β-Lactamase Inhibitors: A Tricyclic Scaffold Enhances Potency against Target Enzymes.苯并杂环金属β-内酰胺酶抑制剂的合理设计:三环支架增强对靶酶的效力。
J Med Chem. 2024 Mar 14;67(5):3795-3812. doi: 10.1021/acs.jmedchem.3c02209. Epub 2024 Feb 19.
8
Synthesis and biological evaluation of novel β-lactam-metallo β-lactamase inhibitors.新型β-内酰胺-金属β-内酰胺酶抑制剂的合成及生物学评价
RSC Adv. 2023 Jun 22;13(28):18991-19001. doi: 10.1039/d3ra02490c.
9
Small-molecule inhibitors of bacterial-producing metallo-β-lactamases: insights into their resistance mechanisms and biochemical analyses of their activities.细菌产生的金属β-内酰胺酶的小分子抑制剂:对其耐药机制的深入了解及其活性的生化分析
RSC Med Chem. 2023 Mar 31;14(6):1012-1048. doi: 10.1039/d3md00036b. eCollection 2023 Jun 22.
10
In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant .β-内酰胺-金属β-内酰胺酶抑制剂的体外和体内研究:针对碳青霉烯类耐药菌。
ACS Infect Dis. 2023 Mar 10;9(3):486-496. doi: 10.1021/acsinfecdis.2c00485. Epub 2023 Feb 14.
探究不同金属-β-内酰胺酶 VIM-2 和 NDM-1 抑制剂的抑制机制。
J Inorg Biochem. 2020 Sep;210:111123. doi: 10.1016/j.jinorgbio.2020.111123. Epub 2020 Jun 15.
4
A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc.头孢菌素螯合剂在不除去锌的情况下抑制新德里金属β-内酰胺酶 1。
ACS Infect Dis. 2020 May 8;6(5):1264-1272. doi: 10.1021/acsinfecdis.0c00083. Epub 2020 Apr 29.
5
Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.小分子羧酸盐可抑制金属β-内酰胺酶并使耐碳青霉烯类细菌对美罗培南重新敏感。
ACS Infect Dis. 2020 Jun 12;6(6):1366-1371. doi: 10.1021/acsinfecdis.9b00459. Epub 2020 Apr 3.
6
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.坦尼硼巴坦(VNRX-5133)的发现:一种用于治疗碳青霉烯类耐药细菌感染的广谱丝氨酸和金属β-内酰胺酶抑制剂。
J Med Chem. 2020 Mar 26;63(6):2789-2801. doi: 10.1021/acs.jmedchem.9b01518. Epub 2019 Dec 16.
7
Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug.利用抗生素耐药性作为新型药物靶点:β-内酰胺酶激活型抗菌前药的开发。
J Med Chem. 2019 May 9;62(9):4411-4425. doi: 10.1021/acs.jmedchem.8b01923. Epub 2019 May 1.
8
OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules.OPLS3e:扩展适用于类药物小分子的力场覆盖范围。
J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874. doi: 10.1021/acs.jctc.8b01026. Epub 2019 Mar 4.
9
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.SAR研究促成了一系列新型金属β-内酰胺酶抑制剂的鉴定,这些抑制剂用于治疗对碳青霉烯类耐药的肠杆菌科细菌感染,且在动物感染模型中显示出疗效。
ACS Infect Dis. 2019 Jan 11;5(1):131-140. doi: 10.1021/acsinfecdis.8b00246. Epub 2018 Nov 30.
10
β-lactam/β-lactamase inhibitor combinations: an update.β-内酰胺类/β-内酰胺酶抑制剂联合制剂:最新进展
Medchemcomm. 2018 Aug 17;9(9):1439-1456. doi: 10.1039/c8md00342d. eCollection 2018 Sep 1.